MDGL — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

18.85

Margin Of Safety %

Put/Call OI Ratio

0.43

EPS Next Q Diff

1.16

EPS Last/This Y

7.07

EPS This/Next Y

18.58

Price

510.96

Target Price

659.53

Analyst Recom

1.28

Performance Q

-15.28

Upside

-188.1%

Beta

-1

Ticker: MDGL

14 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	MDGL	433.76	0.57	0.50	11943
2026-03-10	MDGL	433.51	0.58	0.08	11916
2026-03-11	MDGL	431.1	0.53	1.33	12536
2026-03-12	MDGL	438.76	0.50	0.45	12426
2026-03-13	MDGL	438.73	0.50	0.45	12426
2026-03-17	MDGL	444.45	0.46	0.11	13068
2026-03-18	MDGL	442.89	0.46	0.04	13105
2026-03-19	MDGL	454.94	0.45	0.15	13232
2026-03-20	MDGL	441.32	0.44	5.04	13545
2026-03-23	MDGL	447.96	0.41	0.27	12680
2026-03-24	MDGL	445.37	0.43	1.92	12905
2026-03-25	MDGL	462.09	0.43	0.36	12908
2026-03-26	MDGL	518.77	0.43	0.24	13045
2026-03-27	MDGL	511.43	0.43	0.45	13802
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

14 items 1 of 1

14 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	MDGL	433.67	-22.3	202.0	-5.73
2026-03-10	MDGL	432.75	-22.3	202.2	-5.73
2026-03-11	MDGL	431.54	-22.3	202.4	-5.73
2026-03-12	MDGL	438.42	-24.8	200.9	-5.78
2026-03-13	MDGL	444.66	-24.8	201.1	-5.78
2026-03-17	MDGL	443.39	-24.8	196.1	-5.78
2026-03-18	MDGL	442.46	-24.8	196.6	-5.78
2026-03-19	MDGL	454.39	-24.8	211.4	-5.78
2026-03-20	MDGL	441.16	-24.8	213.1	-5.78
2026-03-23	MDGL	447.51	-24.8	212.3	-5.78
2026-03-24	MDGL	446.45	-24.8	212.4	-5.78
2026-03-25	MDGL	461.85	-24.8	210.5	-5.78
2026-03-26	MDGL	519.15	-24.8	203.1	-5.78
2026-03-27	MDGL	510.96	-24.8	204.2	-5.78
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

14 items 1 of 1

15 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-06	MDGL	-6.08	1.18	17.36
2026-03-09	MDGL	-6.28	1.22	17.36
2026-03-10	MDGL	-5.98	1.22	17.36
2026-03-11	MDGL	-5.98	1.22	17.95
2026-03-12	MDGL	-5.98	1.22	17.95
2026-03-13	MDGL	-5.98	1.22	17.95
2026-03-17	MDGL	-5.98	1.22	17.95
2026-03-18	MDGL	-5.98	1.22	17.95
2026-03-19	MDGL	-5.98	1.22	17.95
2026-03-20	MDGL	-5.98	1.22	17.95
2026-03-23	MDGL	-5.98	1.23	17.95
2026-03-24	MDGL	-5.98	1.23	17.95
2026-03-25	MDGL	-5.98	1.23	18.85
2026-03-26	MDGL	-5.98	1.23	18.85
2026-03-27	MDGL	-5.98	1.23	18.85
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

15 items 1 of 1

Last Quarter Act. EPS

-2.57

Avg. EPS Est. Current Quarter

-4.14

Avg. EPS Est. Next Quarter

-1.41

Insider Transactions

-5.98

Institutional Transactions

1.23

Beta

-1

Average Sales Estimate Current Quarter

301

Average Sales Estimate Next Quarter

349

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

16.9

Max Drawdown 5-Year %

-61.4

Target Price

659.53

P/E

Forward P/E

39.69

PEG

P/S

12.22

P/B

19.35

P/Free Cash Flow

EPS

-12.86

Average EPS Est. Cur. Y

-5.78

EPS Next Y. (Est.)

12.79

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-30.08

Relative Volume

1.33

Return on Equity vs Sector %

-75.2

Return on Equity vs Industry %

-58.9

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-8.13

EBIT Estimation

204.2

◆ MDGL Healthcare

$510.68

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

2/25

Volume

0/15

Valuation

10/20

TP/AR

2/10

Options

6/10

RSI

Range 1M

62%

Sup Dist

10.2%

🚀

Momentum Growth

Ride accelerating trends

WATCH

Momentum

19/25

Growth

23/30

Estimates

1/20

Inst/Vol

6/15

Options

9/10

EPS Yr

65.1%

EPS NY

386.7%

52W%

70.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -0.5% upside

Quality

6/30

Valuation

0/30

Growth

16/25

Stability

6/10

LT Trend

4/5

Upside

-0.5%

Quality

Madrigal Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 915

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

MDGL

Latest News

—

Caricamento notizie per MDGL…

stock quote shares MDGL – Madrigal Pharmaceuticals Inc Stock Price stock today

news today MDGL – Madrigal Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch MDGL – Madrigal Pharmaceuticals Inc yahoo finance google finance

stock history MDGL – Madrigal Pharmaceuticals Inc invest stock market

stock prices MDGL premarket after hours

ticker MDGL fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: MDGL

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y